Trullàs, 100 patient HCQ late treatment study: 36% lower mortality [p=0.12] https://c19p.org/trullas
copied to clipboard
High in-hospital mortality due to COVID-19 in a community hospital in Spain: a prospective observational study
et al., Research Square, doi:10.21203/rs.3.rs-39421/v1 (Preprint)
Retrospective 100 hospitalized patients in Spain showing lower mortality with HCQ+AZ.
|
risk of death, 35.6% lower, RR 0.64, p = 0.12, treatment 20 of 66 (30.3%), control 16 of 34 (47.1%), NNT 6.0.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Trullàs et al., 7/14/2020, retrospective, Spain, Europe, preprint, median age 75.0, 8 authors, average treatment delay 9.0 days.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.